Sandoz Launches Ustekinumab Biosimilar in Europe
Sandoz is launching Pyzchiva, a ustekinumab biosinikar across Europe. Pyzchiva is the first ustekinumab biosimilar to launch in Europe with all reference medicine strengths. Pyzchiva is approved for treatment of adults with plaque psoriasis, psoriatic arthritis, Crohn’s disease and pediatric plaque psoriasis for patients six years and older weighing over 60 kg. Sandoz entered into […]